Bio-Techne Corporation (NasdaqGS:TECH) is looking for M&A. James Hippel, Chief Financial Officer said, "Our balance sheet finished third quarter in a strong position with $157.2 million in cash and short-term available for sale investments. And our total leverage ratio remains below [ 1:10 ]. And going forward, M&A remains a top priority for capital allocation".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.19 USD | -0.08% | -4.46% | +0.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.04% | 1.22TCr | |
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+26.04% | 1.19TCr | |
-11.83% | 1.07TCr | |
-3.38% | 959.71Cr |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Bio-Techne Corporation Seeks M&A